CloudScientific as the local distributor in China of Chemotargets’ CLARITY and CLARITY PV technology platforms
Shanghai, China and Barcelona, Spain – January 17th, 2022. Chemotargets is proud to appoint CloudScientific as the local distributor in China of Chemotargets’ CLARITY® and CLARITY PV technology platforms for off-target safety pharmacology and for translational safety analyses, to better meet the needs of the Chinese pharma and biotech companies.
“We are very excited to enter into this new important distribution partnership with Chemotargets and to introduce Chemotargets’s world-leading solutions for off-target safety pharmacology and for translational safety analyses to the Chinese pharmaceutical and biotech market. It will largely enhance our product portfolio offering to this fast-growing market and accelerate the discovery and development of new medicines with improved efficacy and safety in China. Combined with our well-established customer base, our expertise, and Chemotargets’ renowned products, we are convinced that this cooperation between us will prove to be very fruitful and successful for both of us.” – Jiancheng (Jack) Lin, CEO and Founder of CloudScientific.
Founded in Shanghai in 2009, CloudScientific serves the life sciences community by providing world-leading, integrated scientific software solutions from all over the world. They have over a decade of experience partnering with established software and content providers to accelerate ground-breaking discovery and research in China while helping their partners succeed in China’s emerging market. Over the past 12 years, more than 900 R&D customers in the pharmaceutical, biotechnology, agrochemical and chemical industries – as well as many academic institutes and government organizations – have chosen to partner with CloudScientific for software solutions and services.
“We are very happy to establish this new distribution partnership with CloudScientific in order to serve the Chinese market with Chemotargets’ world-leading technology platforms CLARITY® and CLARITY PV, offering solutions in drug discovery, development and post-marketing. Chemotargets has a well-established client pool worldwide, including the FDA and most of the major pharma companies. We are particularly delighted to expand to drug discovery organizations in China via this new relationship with CloudScientific. Chemotargets solutions allow pharma and biotech companies to thoroughly address issues of drug safety in all phases of development – from early screening to deep analysis of post-marketing side effect patterns. Working with strong and experienced partners such as CloudScientific is key to advancing these solutions in China.” – Scott Boyer, CEO of Chemotargets.
Learn more about CloudScientific.
Learn more about Chemotargets.
